Clinical trial
Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or…
NCT00390234 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00390234 |
|---|---|
| Title | Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma |
| Official title | A Phase II Study of VEGF-Trap in Recurrent or Metastatic Gynecologic Soft-Tissue Sarcomas |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Fallopian Tube Cancer, Female Reproductive Cancer, Ovarian Carcinosarcoma, Ovarian Sarcoma, Recurrent Ovarian Epithelial Cancer, Recurrent Uterine Sarcoma, Stage III Ovarian Epithelial Cancer, Stage III Uterine Sarcoma, Stage IV Ovarian Epithelial Cancer, Stage IV Uterine Sarcoma and 2 more |
| Intervention type | Drug |
| Interventions | ziv-aflibercept |
| Enrollment | 63 |
| Start date | Sep 1, 2006 |
| Primary completion | Sep 1, 2011 |
| Completion | Aug 1, 2013 |
| First posted | Oct 19, 2006 |
| Last update posted | Dec 7, 2015 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: